- Home
- REPL vs MNTK Comparison
REPL vs MNTK Comparison
Compare REPL & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- MNTK
- Stock Information
- Founded
- REPL 2015
- MNTK 1980
- Country
- REPL United States
- MNTK United States
- Employees
- REPL N/A
- MNTK N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- MNTK Natural Gas Distribution
- Sector
- REPL Health Care
- MNTK Utilities
- Exchange
- REPL Nasdaq
- MNTK Nasdaq
- Market Cap
- REPL 578.4M
- MNTK 622.2M
- IPO Year
- REPL 2018
- MNTK 2021
- Fundamental
- Price
- REPL $8.00
- MNTK $2.05
- Analyst Decision
- REPL Strong Buy
- MNTK Hold
- Analyst Count
- REPL 6
- MNTK 3
- Target Price
- REPL $20.00
- MNTK $3.33
- AVG Volume (30 Days)
- REPL 967.9K
- MNTK 272.4K
- Earning Date
- REPL 05-15-2025
- MNTK 05-08-2025
- Dividend Yield
- REPL N/A
- MNTK N/A
- EPS Growth
- REPL N/A
- MNTK N/A
- EPS
- REPL N/A
- MNTK 0.07
- Revenue
- REPL N/A
- MNTK $175,736,000.00
- Revenue This Year
- REPL $31.16
- MNTK $4.25
- Revenue Next Year
- REPL N/A
- MNTK $23.36
- P/E Ratio
- REPL N/A
- MNTK $29.96
- Revenue Growth
- REPL N/A
- MNTK 0.48
- 52 Week Low
- REPL $4.92
- MNTK $1.75
- 52 Week High
- REPL $17.00
- MNTK $6.22
- Technical
- Relative Strength Index (RSI)
- REPL 36.82
- MNTK 41.30
- Support Level
- REPL $6.44
- MNTK $1.94
- Resistance Level
- REPL $7.97
- MNTK $2.20
- Average True Range (ATR)
- REPL 0.73
- MNTK 0.20
- MACD
- REPL 0.08
- MNTK 0.06
- Stochastic Oscillator
- REPL 41.47
- MNTK 47.62
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3.
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a United States-based renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments: Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.